Late Breaking Abstract - Short 12-month regimen with intravenous linezolid for pre-XDR TB: treatment outcomes and 24 months follow-up results

Conclusions: Administration of short 12-month regimen for pre-XDR patients improved the successful treatment outcomes to 90.7% in comparison with the use of conventional regimen. Relapses were only in 3 (4,7 %) patients after conventional 20-month regimen.

Source: European Respiratory Journal - November 20, 2019 Category: Respiratory Medicine Authors: Lytvynenko, N., Pogrebna, M., Senko, J., Protsyk, L., Chobotar, O., Grankina, N., Gumenuk, M. Tags: Tuberculosis Source Type: research